A New York City venture capital firm focused on backing disruptive technologies and innovative pharma solutions has just secured $100K in new capital. Arc Ventures, which operates out of New York City, is known for its expansive investment strategy across a company's entire lifecycle.
The firm seeks to make investments throughout a company's journey, from early-stage pre-revenue ventures to later-stage operating businesses. Its stated preference is for companies developing disruptive technologies and innovative pharma solutions.










